Tumor lysis syndrome screening: Difference between revisions
Jump to navigation
Jump to search
| Line 5: | Line 5: | ||
Screening for tumor lysis syndrome is not recommended. However, patients with malignancies or acute renal failure should be considered for tumor lysis syndrome workup.<ref name="pmid4017246">{{cite journal| author=Nishi HH, Elin RJ| title=Three turbidimetric methods for determining total protein compared. | journal=Clin Chem | year= 1985 | volume= 31 | issue= 8 | pages= 1377-80 | pmid=4017246 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4017246 }} </ref> | Screening for tumor lysis syndrome is not recommended. However, patients with malignancies or acute renal failure should be considered for tumor lysis syndrome workup.<ref name="pmid4017246">{{cite journal| author=Nishi HH, Elin RJ| title=Three turbidimetric methods for determining total protein compared. | journal=Clin Chem | year= 1985 | volume= 31 | issue= 8 | pages= 1377-80 | pmid=4017246 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4017246 }} </ref> | ||
==Screening== | ==Screening== | ||
*Screening for tumor lysis syndrome is not recommended | *Screening for tumor lysis syndrome is not recommended. | ||
*Patients with malignancies or acute renal failure should be considered for tumor lysis syndrome workup<ref name="pmid4017246">{{cite journal| author=Nishi HH, Elin RJ| title=Three turbidimetric methods for determining total protein compared. | journal=Clin Chem | year= 1985 | volume= 31 | issue= 8 | pages= 1377-80 | pmid=4017246 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4017246 }} </ref> | *Patients with malignancies or acute renal failure should be considered for tumor lysis syndrome workup.<ref name="pmid4017246">{{cite journal| author=Nishi HH, Elin RJ| title=Three turbidimetric methods for determining total protein compared. | journal=Clin Chem | year= 1985 | volume= 31 | issue= 8 | pages= 1377-80 | pmid=4017246 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4017246 }} </ref> | ||
==References== | ==References== | ||
Revision as of 13:08, 22 September 2015
|
Tumor lysis syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tumor lysis syndrome screening On the Web |
|
American Roentgen Ray Society Images of Tumor lysis syndrome screening |
|
Risk calculators and risk factors for Tumor lysis syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Screening for tumor lysis syndrome is not recommended. However, patients with malignancies or acute renal failure should be considered for tumor lysis syndrome workup.[1]
Screening
- Screening for tumor lysis syndrome is not recommended.
- Patients with malignancies or acute renal failure should be considered for tumor lysis syndrome workup.[1]
References
- ↑ 1.0 1.1 Nishi HH, Elin RJ (1985). "Three turbidimetric methods for determining total protein compared". Clin Chem. 31 (8): 1377–80. PMID 4017246.